{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T09:10:01Z","timestamp":1790327401075,"version":"4.1.0"},"reference-count":38,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Med.","JCM"],"abstract":"<jats:p>Background: Fabry disease may cause clinically silent kidney involvement before marked loss of kidney function. Objectives: To characterize pediatric and adult patients with Fabry disease, focusing on early kidney findings and age-related organ involvement. Methods: This retrospective, single center study included 16 patients followed between 2016 and 2026. GLA variants were identified by targeted next-generation sequencing. Patients were classified as children (\u226418 years, n = 7) or adults (&gt;18 years, n = 9) at the final evaluation. Results: Family screening identified 10 of 16 patients from six families. Six of these ten patients had no complaints before diagnosis. The median age at diagnosis was 24.5 years (range, 7\u201360). In nine patients with known symptom onset, the median onset age was 14 years (range, 8\u201335), and the diagnostic delay was 8 years (range, 1\u201330). At baseline, proteinuria was detected in eight (50%), hematuria in seven (43.8%), and hypertension in three patients (18.8%). Children had no hypertension or marked kidney dysfunction, although proteinuria and hematuria were each observed in two. Among adults, proteinuria occurred in six, microscopic hematuria in five, and hypertension in three. Left ventricular hypertrophy and valvular abnormalities occurred only in adults. At the final evaluation, proteinuria was present in 10 patients (62.5%). One adult experienced an estimated glomerular filtration rate decline from 70 to 14 mL\/min\/1.73 m2 and required kidney replacement therapy. Conclusions: The diagnostic delay underscores the value of family screening. At baseline, proteinuria and hematuria were observed in both age groups, whereas hypertension, cardiac abnormalities, and advanced kidney dysfunction were confined to adults. During follow-up, hypertension developed in one pediatric patient. These findings support kidney surveillance from childhood onward.<\/jats:p>","DOI":"10.3390\/jcm15197456","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T08:09:02Z","timestamp":1790323742000},"page":"7456","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical and Laboratory Characteristics of Fabry Disease in Children and Adults: A Focus on Early Kidney Findings"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2148-1160","authenticated-orcid":false,"given":"Okan","family":"Akac\u0131","sequence":"first","affiliation":[{"name":"Department of Pediatric Nephrology, University of Health Sciences, Bursa Y\u00fcksek \u0130htisas Training and Research Hospital, Bursa 16310, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"supervision","vocabulary":"credit"},{"role":"conceptualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6947-2573","authenticated-orcid":false,"given":"Sevil","family":"Y\u0131ld\u0131z","sequence":"additional","affiliation":[{"name":"Department of Pediatric Nutrition and Metabolism, University of Health Sciences, Bursa Y\u00fcksek \u0130htisas Training and Research Hospital, Bursa 16310, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"given":"Nimet","family":"Akta\u015f","sequence":"additional","affiliation":[{"name":"Department of Nephrology, University of Health Sciences, Bursa Y\u00fcksek \u0130htisas Training and Research Hospital, Bursa 16310, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"investigation","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.ymgme.2018.02.014","article-title":"Fabry disease revisited: Management and treatment recommendations for adult patients","volume":"123","author":"Ortiz","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13023-022-02215-x","article-title":"Expert opinion on the recognition, diagnosis and management of children and adults with Fabry disease: A multidisciplinary Turkey perspective","volume":"17","author":"Ezgu","year":"2022","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s10545-007-0521-2","article-title":"Fabry disease: Baseline medical characteristics of a cohort of 1765 males and females in the Fabry Registry","volume":"30","author":"Eng","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.2215\/CJN.04340510","article-title":"Prognostic indicators of renal disease progression in adults with Fabry disease: Natural history data from the Fabry Registry","volume":"5","author":"Wanner","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/cge.13546","article-title":"Consensus recommendations for diagnosis, management and treatment of Fabry disease in paediatric patients","volume":"96","author":"Germain","year":"2019","journal-title":"Clin. Genet."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ymgme.2015.10.007","article-title":"The management and treatment of children with Fabry disease: A United States-based perspective","volume":"117","author":"Hopkin","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.gene.2013.05.050","article-title":"Screening for Fabry disease in patients undergoing dialysis for chronic renal failure in Turkey: Identification of new case with novel mutation","volume":"527","author":"Okur","year":"2013","journal-title":"Gene"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1159\/000452605","article-title":"The prevalence of Fabry disease in patients with chronic kidney disease in Turkey: The TURKFAB Study","volume":"41","author":"Turkmen","year":"2016","journal-title":"Kidney Blood Press. Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"444","DOI":"10.6002\/ect.2019.0279","article-title":"Fabry disease screening in patients with kidney transplant: A single-center study in Turkey","volume":"18","author":"Erdogmus","year":"2020","journal-title":"Exp. Clin. Transplant."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1542\/peds.58.2.259","article-title":"A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine","volume":"58","author":"Schwartz","year":"1976","journal-title":"Pediatrics"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine- and cystatin C-based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"(2024). Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int., 105, S117\u2013S314.","DOI":"10.1016\/j.kint.2023.10.018"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e20171904","DOI":"10.1542\/peds.2017-1904","article-title":"Clinical practice guideline for screening and management of high blood pressure in children and adolescents","volume":"140","author":"Flynn","year":"2017","journal-title":"Pediatrics"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur. Heart J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.clinbiochem.2014.02.014","article-title":"Fabry disease: A new approach for the screening of females in high-risk groups","volume":"47","author":"Pasqualim","year":"2014","journal-title":"Clin. Biochem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1399-0004.2004.00219.x","article-title":"The Mainz Severity Score Index: A new instrument for quantifying the Anderson\u2013Fabry disease phenotype and the response of patients to enzyme replacement therapy","volume":"65","author":"Whybra","year":"2004","journal-title":"Clin. Genet."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ymgme.2010.06.002","article-title":"Age adjusting severity scores for Anderson\u2013Fabry disease","volume":"101","author":"Hughes","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Kalkum, G., Pitz, S., Karabul, N., Beck, M., Pintos-Morell, G., Parini, R., Rohrbach, M., Bizjajeva, S., and Ramaswami, U. (2016). Paediatric Fabry disease: Prognostic significance of ocular changes for disease severity. BMC Ophthalmol., 16.","DOI":"10.1186\/s12886-016-0374-2"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1651-2227.2003.tb00212.x","article-title":"Studio Multicentrico Italiano sulla Malattia di Anderson-Fabry. Evolution of renal pathology in Fabry disease","volume":"92","author":"Sessa","year":"2003","journal-title":"Acta Paediatr. Suppl."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1651-2227.2008.00658.x","article-title":"Fabry disease during childhood: Clinical manifestations and treatment with agalsidase alfa","volume":"97","author":"Ramaswami","year":"2008","journal-title":"Acta Paediatr."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e1912","DOI":"10.1002\/mgg3.1912","article-title":"Gene variants of unknown significance in Fabry disease: Clinical characteristics of c.376A>G (p.Ser126Gly)","volume":"10","author":"Lau","year":"2022","journal-title":"Mol. Genet. Genom. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/cge.14102","article-title":"Challenging the traditional approach for interpreting genetic variants: Lessons from Fabry disease","volume":"101","author":"Germain","year":"2022","journal-title":"Clin. Genet."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/gim.2016.55","article-title":"Is it Fabry disease?","volume":"18","author":"Schiffmann","year":"2016","journal-title":"Genet. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ymgme.2016.10.006","article-title":"Plasma LysoGb3: A useful biomarker for the diagnosis and treatment of Fabry disease heterozygotes","volume":"120","author":"Nowak","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Duro, G., Anania, M., Zizzo, C., Francofonte, D., Giacalone, I., D\u2019Errico, A., Marsana, E.M., and Colomba, P. (2024). Diagnosis of Fabry disease using alpha-galactosidase A activity or LysoGb3 in blood fails to identify up to two thirds of female patients. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25105158"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00109-005-0656-2","article-title":"Relationship between X-inactivation and clinical involvement in Fabry heterozygotes. Eleven novel mutations in the alpha-galactosidase A gene in the Czech and Slovak population","volume":"83","author":"Dobrovolny","year":"2005","journal-title":"J. Mol. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1203\/PDR.0b013e318183f132","article-title":"Characterization of Fabry disease in 352 pediatric patients in the Fabry Registry","volume":"64","author":"Hopkin","year":"2008","journal-title":"Pediatr. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"117","DOI":"10.12956\/tchd.820757","article-title":"Retrospective evaluation of clinical and molecular characteristics of patients with Fabry disease being followed-up in our clinic","volume":"15","author":"Kasapkara","year":"2021","journal-title":"Turk. J. Pediatr. Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1053\/j.ajkd.2007.12.032","article-title":"Renal biopsy findings in children and adolescents with Fabry disease and minimal albuminuria","volume":"51","author":"Bostad","year":"2008","journal-title":"Am. J. Kidney Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/ki.2010.484","article-title":"Progressive podocyte injury and globotriaosylceramide (GL-3) accumulation in young patients with Fabry disease","volume":"79","author":"Najafian","year":"2011","journal-title":"Kidney Int."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1093\/ndt\/gfp031","article-title":"Fabry disease: Progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy","volume":"24","author":"Schiffmann","year":"2009","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1136\/jmedgenet-2015-103471","article-title":"Antiproteinuric therapy and Fabry nephropathy: Factors associated with preserved kidney function during agalsidase-beta therapy","volume":"52","author":"Warnock","year":"2015","journal-title":"J. Med. Genet."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/ejhf.1960","article-title":"An expert consensus document on the management of cardiovascular manifestations of Fabry disease","volume":"22","author":"Linhart","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/eurheartj\/ehm153","article-title":"Cardiac manifestations of Anderson\u2013Fabry disease: Results from the international Fabry outcome survey","volume":"28","author":"Linhart","year":"2007","journal-title":"Eur. Heart J."},{"key":"ref_35","first-page":"53","article-title":"Early cardiac changes in children with Anderson\u2013Fabry disease","volume":"11","author":"Havranek","year":"2013","journal-title":"JIMD Rep."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s10545-017-0051-5","article-title":"Hearing loss in children with Fabry disease","volume":"40","author":"Suntjens","year":"2017","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jpeds.2005.03.004","article-title":"Radiological evidence of early cerebral microvascular disease in young children with Fabry disease","volume":"147","author":"Barranger","year":"2005","journal-title":"J. Pediatr."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.cgh.2007.08.012","article-title":"Fabry Outcome Survey European Investigators. Gastrointestinal symptoms in 342 patients with Fabry disease: Prevalence and response to enzyme replacement therapy","volume":"5","author":"Hoffmann","year":"2007","journal-title":"Clin. Gastroenterol. Hepatol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/19\/7456\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T08:33:46Z","timestamp":1790325226000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/19\/7456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":38,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["jcm15197456"],"URL":"https:\/\/doi.org\/10.3390\/jcm15197456","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]}}}